SLC25A22 and epilepsy: Eight of these proteins were significantly decreased in both epilepsy and AD (DNM1, PURA, STXBP1, GNAO1, SCN2A, SLC25A22, SYNGAP1, SYNJ1), while SCARB2 was increased in both epilepsy and AD.